OrbiMed and Third Rock’s Terremoto Biosciences raises $175M for small molecule R&D

Terremoto Biosciences has reeled in $175 million to create small molecules based on work from Principia Biopharma co-founder Jack Taunton and Global Blood Therapeutics co-founder Matthew Jacobson.

Jack Taunton

The Series B arrives 18 months after the South San Francisco…
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks